q.beyond AG

  • WKN: 513700
  • ISIN: DE0005137004
  • Land: Deutschland

Nachricht vom 20.06.2019 | 12:06

DGAP-DD: QSC AG english


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

20.06.2019 / 12:05
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Jürgen
Last name(s): Hermann

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
QSC AG

b) LEI
529900DGVITE7A2L5G12 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE0005137004

b) Nature of the transaction
Purchase (Transaction has been executed via joint deposit of securities held together with wife Marget Hermann)

c) Price(s) and volume(s)
Price(s) Volume(s)
1.38 EUR 41400.00 EUR

d) Aggregated information
Price Aggregated volume
1.38 EUR 41400.00 EUR

e) Date of the transaction
2019-06-19; UTC+2

f) Place of the transaction
Name: Quotrix
MIC: XQTX



20.06.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021